| 29.04.2024 10:59 | N4P | Posting of Annual Report & Notice of AGM | RNS |
| 26.04.2024 07:00 | N4P | N4 Pharma Webinar on SRI Collaboration | Reach |
| 25.04.2024 11:56 | N4P | N4 Pharma strikes partnership deal for intracellular delivery | Alliance |
| 25.04.2024 07:38 | N4P | Collaboration Agreement with SRI International Inc | RNS |
| 23.04.2024 13:32 | N4P | IN BRIEF: N4 Pharma loss widens but "great optimism" remains | Alliance |
| 23.04.2024 07:00 | N4P | Final Results | RNS |
| 18.04.2024 12:14 | N4P | N4 Pharma sees potential in Nuvec delivery method for cancer treatment | Alliance |
| 18.04.2024 07:00 | N4P | Oral Delivery Update | RNS |
| 04.03.2024 15:13 | N4P | Holding(s) in Company | RNS |
| 29.02.2024 07:00 | N4P | Holding(s) in Company | RNS |
| 15.02.2024 12:06 | N4P | IN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec research | Alliance |
| 15.02.2024 10:52 | DSW, SAR, N4P | AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets | Alliance |
| 15.02.2024 07:00 | N4P | in-vitro siRNA update | RNS |
| 19.01.2024 09:26 | N4P | IN BRIEF: N4 Pharma gets India patent for medical delivery system | Alliance |
| 19.01.2024 07:00 | N4P | Patent Grant | RNS |
| 18.01.2024 10:15 | N4P | Holding(s) in Company | RNS |
| 16.01.2024 13:26 | N4P | IN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105 | Alliance |
| 16.01.2024 07:00 | N4P | Nanogenics Update | RNS |
| 08.01.2024 16:24 | N4P | Holding(s) in Company | RNS |
| 08.01.2024 09:11 | N4P | N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8 | Alliance |
| 08.01.2024 07:00 | N4P | AAV Viral Vector Update | RNS |
| 18.12.2023 12:43 | N4P | N4 Pharma rises on successful results from Nuvec administration | Alliance |
| 18.12.2023 07:00 | N4P | Oral Delivery Update | RNS |
| 07.12.2023 18:28 | RNEW, SFT, N4P | TRADING UPDATES: N4 Pharma hails "encouraging" siRNA research | Alliance |
| 07.12.2023 11:28 | N4P | Holding(s) in Company | RNS |
| 07.12.2023 07:00 | N4P | Nuvec® R&D and Strategy Update | RNS |
| 01.12.2023 14:29 | SOLG, KDNC, PRTC | TRADING UPDATES: N4 launches investor hub; Capricorn production falls | Alliance |
| 30.11.2023 09:00 | N4P | N4 Pharma Launches New Interactive Investor Hub | Reach |
| 31.10.2023 07:00 | N4P | Total Voting Rights | RNS |
| 09.10.2023 07:00 | N4P | Investor Presentation via Investor Meet Company | Reach |
| 03.10.2023 08:15 | N4P | Holding(s) in Company | RNS |
| 02.10.2023 07:00 | N4P | Investor Presentation | Reach |
| 28.09.2023 10:20 | N4P | N4 Pharma shares fall as places shares to fund Nanogenics stake buy | Alliance |
| 28.09.2023 07:00 | N4P | Acquisition of Controlling Interest in Nanogenics | RNS |
| 12.09.2023 13:43 | N4P | N4 Pharma interim loss narrows slightly as business outreach ongoing | Alliance |
| 12.09.2023 07:00 | N4P | Interim Results | RNS |
| 25.07.2023 10:12 | N4P | N4 Pharma shares soar on further patent grant for Nuvec in US | Alliance |
| 25.07.2023 10:04 | PIER, AFRN, N4P | AIM WINNERS & LOSERS: N4 Pharma shares jump on grant of US patent | Alliance |
| 25.07.2023 07:00 | N4P | Patent Grant and Board Change | RNS |
| 27.06.2023 12:13 | N4P | IN BRIEF: N4 Pharma expands Professor Yu partnership on grant award | Alliance |
| 27.06.2023 07:00 | N4P | Grant Award for Professor Chengzhong Yu | Reach |
| 25.04.2023 16:19 | GILD, LGRS, N4P | TRADING UPDATES: Eckoh expects profit up; LXi REIT refinances facility | Alliance |
| 25.04.2023 10:30 | N4P, ECK, SML | AIM WINNERS & LOSERS: FireAngel 2023 earnings below expectations | Alliance |
| 25.04.2023 07:00 | N4P | siRNA update | RNS |
| 18.04.2023 14:20 | JNEO, BIOM, TLY | TRADING UPDATES: Journeo extends contract; Biome completes fundraise | Alliance |
| 18.04.2023 07:00 | N4P | siRNA update | RNS |
| 03.04.2023 14:11 | N4P | Result of AGM | RNS |
| 27.03.2023 15:50 | TRCS, RNWH, N4P | UK earnings, trading statements calendar - next 7 days | Alliance |
| 09.03.2023 14:32 | TLOU, SSIT, N4P | EARNINGS SUMMARY: Franchise Brands blooms; Tlou Energy loss widens | Alliance |
| 09.03.2023 07:00 | N4P | Posting of Annual Report & Notice of AGM | RNS |
| 09.03.2023 07:00 | N4P | Final Results | RNS |
| 14.02.2023 16:40 | N4P | Second Price Monitoring Extn | RNS |
| 14.02.2023 16:35 | N4P | Price Monitoring Extension | RNS |
| 17.01.2023 16:23 | N4P, AVCT, ECOR | TRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares | Alliance |
| 17.01.2023 14:05 | N4P | Second Price Monitoring Extn | RNS |
| 17.01.2023 14:00 | N4P | Price Monitoring Extension | RNS |
| 17.01.2023 11:05 | N4P | Second Price Monitoring Extn | RNS |
| 17.01.2023 11:00 | N4P | Price Monitoring Extension | RNS |
| 17.01.2023 09:05 | N4P | Second Price Monitoring Extn | RNS |
| 17.01.2023 09:00 | N4P | Price Monitoring Extension | RNS |
| 17.01.2023 07:00 | N4P | Oral application update | RNS |
| 30.11.2022 17:28 | N4P | Holding(s) in Company | RNS |
| 30.11.2022 07:00 | N4P | Total Voting Rights | RNS |
| 25.11.2022 14:49 | N4P | Holding(s) in Company | RNS |
| 22.11.2022 10:50 | N4P | Result of Broker Offer and Total Voting Rights | RNS |
| 18.11.2022 11:16 | N4P, ECO, MHC | AIM WINNERS & LOSERS: Parsley Box to exit AIM as shares wilt since IPO | Alliance |
| 18.11.2022 11:02 | N4P | N4 Pharma plummets on broker offer to raise up to GBP1 million | Alliance |
| 18.11.2022 07:01 | N4P | Broker Offer to raise a maximum of £1 million | RNS |
| 18.11.2022 07:00 | N4P | Placing to raise £1million and Broker Offer | RNS |
| 01.11.2022 17:06 | N4P | IN BRIEF: N4 Pharma expands patent application claims for Nuvec | Alliance |
| 01.11.2022 07:00 | N4P | Patent filing update | RNS |
| 04.10.2022 11:19 | AGY, WJG, N4P | AIM WINNERS & LOSERS: N4's Nuvec success; Watkin Jones tumbles | Alliance |
| 04.10.2022 10:38 | N4P | N4 Pharma announces successful test in next stage of Nuvec development | Alliance |
| 04.10.2022 07:00 | N4P | Double siRNA Testing Update | RNS |
| 29.09.2022 15:09 | LOGP, GUS, CEL | EARNINGS UPDATES: Crestchic raises outlook on record year-to-date | Alliance |
